Results 11 to 20 of about 911,773 (309)

Opportunities and Challenges: Hepatitis C Testing and Treatment Access Experiences Among People in Methadone and Buprenorphine Treatment During COVID-19, Arizona, 2021

AJPM Focus, 2023
Introduction: The purpose of this study was to characterize hepatitis C virus screening and treatment access experiences among people in treatment for opioid use disorder in Arizona during COVID-19.
Beth E. Meyerson, PhD, Danielle M. Russell, MS, Missy Downer, BS, Amirah Alfar, Irene Garnett, MLIS, John Lowther, Rebecca Lutz, Arlene Mahoney, BSW, Julie Moore, Greg Nuñez, Savannah Samorano, AA, Benjamin R. Brady, DrPH, Keith G. Bentele, PhD, Brenda Granillo, DBH   +13 more
doaj   +1 more source

Global Distribution and Prevalence of Hepatitis C Virus Genotypes

Hepatology, 2014
Hepatitis C virus (HCV) exhibits high genetic diversity, characterized by regional variations in genotype prevalence. This poses a challenge to the improved development of vaccines and pan‐genotypic treatments, which require the consideration of global ...
J. Messina, I. Humphreys, A. Flaxman, Anthony Brown, G. Cooke, O. Pybus, E. Barnes   +6 more
semanticscholar   +1 more source

Performance study of the automated immunoassay test anti-hepatitis C virus VIDAS® for the qualitative detection of antibodies anti-hepatitis C virus

Microbiologia Medica, 2016
Background and aims: Hepatitis C virus (HCV) represents a major worldwide public health problem requiring global action for the diagnosis, treatment and prevention of this infection.
Sara Salvetti, Federica Lavinia, Iolanda Montenora   +2 more
doaj   +1 more source

Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients

Brazilian Journal of Infectious Diseases, 2014
Aim: To evaluate changes in liver histology in patients with human immunodeficiency virus/hepatitis C virus coinfection non-responders to a suboptimal Interferon + Ribavirine regimen. Materials and methods: We investigated 49 patients with two sequential
Caterina Sagnelli, Caterina Uberti-Foppa, Laura Galli, Giuseppe Pasquale, Nicola Coppola, Luca Albarello, Carlo Doglioni, Adriano Lazzarin, Evangelista Sagnelli   +8 more
doaj   +1 more source

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

Nature, 2009
Hepatitis C virus (HCV) infection is the most common blood-borne infection in the United States, with estimates of 4 million HCV-infected individuals in the United States and 170 million worldwide.
David L. Thomas, C. Thio, Maureen P. Martin, Y. Qi, D. Ge, C. O’hUigin, J. Kidd, K. Kidd, S. Khakoo, G. Alexander, J. Goedert, G. Kirk, S. Donfield, H. Rosen, L. Tobler, M. Busch, J. Mchutchison, D. Goldstein, M. Carrington   +18 more
semanticscholar   +1 more source

Immune restoration in human immunodeficiency virus and hepatitis C virus coinfected patients after highly active antiretroviral therapy

Brazilian Journal of Infectious Diseases, 2013
Objective: To evaluate the influence of hepatitis C virus on immunological and virological responses after highly active antiretroviral therapy initiation in human immunodeficiency virus/hepatitis C virus coinfected patients compared to monoinfected ...
Vicente Sperb Antonello, Marcelo Campos Appel-da-Silva, Dimas Alexandre Kliemann, Breno Riegel Santos, Cristiane Valle Tovo   +4 more
doaj   +3 more sources

Delayed Viral Clearance after 6-Week Treatment with Peginterferon Plus Ribavirin in a Patient with Chronic Hepatitis C Virus Genotype 1b

Case Reports in Gastroenterology, 2016
Following interferon-based therapy for chronic hepatitis C, the negativity of hepatitis C virus RNA is essential to achieve viral clearance at the end of treatment.
Akira Sato, Toshiya Ishii, Kayo Adachi, Hideaki Takahashi, Fumiaki Sano, Nobuyuki Matsumoto   +5 more
doaj   +1 more source

Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes

World Journal of Gastroenterology, 2016
AIM To review Hepatitis C virus (HCV) prevalence and genotypes distribution worldwide. METHODS We conducted a systematic study which represents one of the most comprehensive effort to quantify global HCV epidemiology, using the best available published ...
A. Petruzziello, Samantha Marigliano, Giovanna Loquercio, A. Cozzolino, C. Cacciapuoti   +4 more
semanticscholar   +1 more source

Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

Hepatology, 2019
The American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) initiated the hepatitis C guidance project (hereafter HCV guidance) in 2013. The AASLD-IDSA HCV guidance website (www.HCVGuidelines.org)
M. Ghany, Kristen M. Marks, Timothy R. Morgan, D. Wyles, A. Aronsohn, D. Bhattacharya, Tina Broder, Oluwaseun O Falade-Nwulia, Jordan J. Feld, Stuart C. Gordon, Theo Heller, Ravi R Jhaveri, Maureen M Jonas, Jennifer J Kiser, B. Linas, Vincent Lo Re, Marion G Peters, K. R. Reddy, Andrew Reynolds, John D Scott, Gloria Searson, P. Spradling, Norah A. Terrault, Stacey Trooskin, E. Verna, John B Wong, A. Woolley, K. A. Workowski   +27 more
semanticscholar   +1 more source

Screening for Hepatitis C Among Community Health Center Patients by Ethnicity and Language Preference

AJPM Focus, 2023
Introduction: Hepatitis C virus is associated with high morbidity and mortality—chronic liver disease is a leading cause of death among Latinos in the U.S.
Brian L. Chan, MD, MPH, David Ezekiel-Herrera, MS, Steffani R. Bailey, PhD, Miguel Marino, PhD, Jennifer A. Lucas, PhD, MPH, Sophia Giebultowicz, MS, Erika Cottrell, PhD, MPP, Joe Carroll, MD, John Heintzman, MD, MPH   +8 more
doaj   +1 more source